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Summary.-A preliminary announcement of a new in vitro blood test for cancer by
Field and Caspary appeared in the Lancet of 26 December 1970. The test depends
on sensitization of the patient's lymphocytes to a common antigen apparently present
in human tumours. We now offer independent confirmation of these findings,
together with methods for improving the test towards its future clinical use.
FIELD AND CASPARY (1970, 1972)
reported that peripheral lymphocytes from
patients with malignant disease are sensi-
tized to a basic protein derived from
human brain (Encephalitogenic Factor;
EF). Incubation with this antigen stimu-
lates sensitized lymphocytes to release a
substance (Macrophage Slowing Factor;
MSF) which reduces the electrophoretic
mobility of macrophages isolated from the
peritoneal exudate of Hartley albino
guinea-pigs. Lymphocytes from persons
free from malignant disease showed no
such effect, although sensitization to EF
was found in a small number of neuro-
logical conditions that involve destruction
of nervous parenchyma. In a further
paper Caspary and Field (1971) claimed
that malignant disease could be distin-
guished from these neurological conditions
by the slightly greater reduction in
mobility when EF was replaced by a
basic protein derived from human
tumours, suggesting that human neoplasia
produce a common antigen.
A common antigen in human tumours
was unexpected and raised the important
possibility of developing and applying the
technique as an in vitro blood test for
cancer, particularly as Field and Caspary
observed slowing of macrophages with
early as well as with advanced neoplasia.
Unlike many biologically based tests, the
macrophage electrophoretic mobility
(MEM) test achieved a clear separation of
the " malignant " and " normal " sub-
jects. The importance of these findings
persuaded us to carry out a similar
investigation in Cardiff, and a preliminary
report confirming the Newcastle results
has already been presented (Pritchard et
al., 1972). This paper provides further
details of the techniques involved in the
MEM test, and reports a inumber of
modifications designed to improve its
value as a clinical procedure.
MATERIALS AND METHODS
Approximately 15 nml of venous blood was
collected from healthy hospital staff and from
patients with malignant disease. The blood
was placed in a siliconized Universal con-
tainer along with about 40 small (3 mm)
glass beads. The silicon-rubber lined cap was
replaced and defibrination carried out by
continuous inversion until a fibrin clot
resulted (usually 5-15 min). The defibrinated
blood was pipetted into a 15 ml siliconized
centrifuge tube, noting the volume, and
centrifuged at 1500 g for 10 min in a swing
out head. Lymphocytes were harvested
either by (a) a methylcellulose technique as
used by Hughes and Caspary (1970) and
Caspary and Field (1971), or (b) a Ficol-
Triosil technique (J. A. Forrester, private
communication). For the latter, 9 g of Ficol
was dissolved in 100 ml of distilled water;
24 ml of distilled water was added to 20 ml
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Triosil was then added to 100 ml of the 9%
Ficol and the mixture stored in a dark bottle
at 4°C. AIn aliquot of 3 ml of the Ficol-
Triosil solution was stored in a siliconized
centrifuge tube at 37°C for later use. The
buffy coat at the interface of the defibrinated
blood after centrifugation was diluted with
about twice its volume of medium 199
(Gibco) and this was layered on to the surface
of the 3 ml aliquot of Ficol-Triosil, which
should not be allowed to stand for longer
than 2 min before centrifugation at 1500 g
for 20 min. The liquid was carefully collected
down as far as the interface between medium
199 and Ficol-Triosil and added to 8 ml of
medium 199. The lymphocytes from either
technique were washed 3 times by centrifuga-
tion at 1500 g for 10 min and resuspended in
medium 199. Permanent slides stained with
Jenner (Geimsa were made of every prepara-
tion for cell counting.
For macrophage production, 20 ml of
sterile liquid paraffin BP was injected into
the peritoneum of 400-600 g Hartley albino
guinea-pigs. Four to 10 days laterthe animals
were exsanguinated and 60 ml of Hanks
solution containing 5 units of heparin/ml
(preservative free) injected into the peritoneal
cavity. The abdomen was gently pummelled
and then opened and the peritoneal exudate
transferred with a 10 ml pipette into centri-
fuge tubes. The excess liquid paraffin was
pipetted off the top and the macrophages
washed once with Hanks/heparin solution
and twice with medium 199 and resuspended
so that the cell concentration was 107/ml.
Each suspension w%as irradiated to a dose of
150-200 rad from a 137Caesium source.
The encephalitogenic factor (EF) was
prepared from a human brain by the method
described by Caspary and Field (1965, 1971).
For use, 1D0 mg was dissolved in medium 199
so that the final concentration was 100 )ug/
041 ml.
Electrophoretic rnieasurements
10 ml of medium 199 was put in a bijou
bottlefollow ed by0 1 ml ofantigen in medium
199, 1 0 ml ofthe lymphocyte preparation and
1.0 ml of the macrophage suspension. This
final volume of 3 1 ml wNas sufficient to fill the
Zeiss Cytopherometer. It is important to
keep the pH of all solutions as near to 7-2 as
possible. Each sample stood at room
temperature (20-23°C) for at least 90 min
before being run slowly, taking about 20 sec,
into the Zeiss instrument. Cells in focus in
the stationary layer were selected and
measured over one square of the eyepiece
graticule (= 16 [km) in both directions, and
the pairs of times averaged if they did not
differ by more than 10%. Such differences
are due to several factors: sample turbulence
or drifting due to non-uniform temperature;
microleaks at taps or joints; cell collisions;
small gas bubbles in the test chamber, etc.
Usually betwNeen 20% and 4000 of all timings
were rejected for failing to meet the arbitrary
10% standard. It should be emphasized that
the intention in the first phase of this investi-
gation was to verify the Newcastle findings,
using the techniques described by Field and
Caspary. The somewhat empirical methods
of data selection and handling were justified
partly by this limited intention and partly by
the lack of detailed knowledge of all the
parameters affecting the test. A more
rigorous examination of these parameters
must wait for a later phase of the investi-
gation.
A second lymphocyte/macrophage sus-
pension without EF was made up from every
sample and measured to give the "' control "
value for that sample. The constancy of the
timings from these controls during each day's
run, and from week to week, is a good guide
to the state of the apparatus and technique.
A retrospective analysis of the results on
which this report is based showed that the
extreme variation in the timings from control
samples without EF over 4 months was
surprisingly small at ± 2.2%. Samples were
"scrambled " so that those containing EF
and control samples without EF wtere mixed
and presented for blind measurement in a
random order, except where the test was part
of a concurrent investigation that precluded
scrambling. Sets of times from one
" normal " and tvwo " malignant " samples
are sho- 1n in Table I. Unlike the results
quoted by Field and Caspary, each individual
macrophage timing did not always fall with
certainty into the appropriate category of
'normal " or " malignant ". The tiines
Nwere therefore recorded in twvo columns, one
containing all pairs which averaged 3-3 sec
or less (A in Table 1) and the other column
containing any pairs that averaged morethan
3-3 sec (B in Table I). Measurements on each
sample were stopped as soon as one column
had accumulated 10 good pairs. and these
wA-ere then averaged and used as the resultTHE MEM TEST FOR MALIGNANT DISEASE
TABLE I.-Typical Record of Timings from 3 Consecutive Samples (Timees are in Seconds)
Sample No. 291 Sample No. 292 Sample No. 293
No EF With EF No EF With EF No EF With EF
A B A B A B A B A B A B
:-.0 3 0 3-6 3-0 3-6 2-8 3 0 3-5
.3-2 3-1 3-6 2-8 '3 8 3-1 3 1 3-6
2-9 2-9 3-8 3-0 3-4 2-9 3-1 3-7
3 0 2-8 3-8 3-3 3-5 3'0 3 3 4-1
3 0 3-2 3-1 3-6 3 0 3-8
:3-1 3-2 3-2 3-7 3-2 4-2
3 0 2-8 2-9 3-5 3-3 3-3
2-8 2-8 3-1 3-7 3-3 3-6
3 0 3-2 28 3-4 2-8 3-4
3-2 3-1 29 3-4 2-8 3-7
3 0 3-0 2-9 3-5 2-7 3-.
3-3 3-2 3-1 3-7 2-8 3-8
2-8 3 0 3:0 3-5 3-2 3-4
2-9 3-3 3-3 3-8 3-3 3-4
2-9
3 1
2-7
2 9
2-8
3 0
2 98
3 - i
3 2 2
2-9
2-9
3-3
3-2
3 06
2 7°,
3-6 2-9
3-8 2-8
:3 0
3.3
3 1 2-8
28-0
3-3
3.4
:3.4
36-e
3-56
17-9%
2-9
:3-0
2-9
:3-0
2- 985
3.5
3.5
3.-4
3.5
3.5
3-6
3-60
20.6 60
from that sample. The inclusion of all of the
timings from both columns would not have
caused a single false result in our series.
Nevertheless, this method of recording gave
useful information about the state of the
technique from day to day.
Table II shows a retrospective analysis of
the numbers of "w wrong " pairs in each ofthe
four categories of suspension as the investi-
gation proceeded, expressed as a percentage
of the numbers of "right " pairs from
successive groups of 10 " malignant " or 5
"; normal " samples. The table starts from
May 1972 (top line) and covers the 3 months
represented by the block of 79 samples which
confirmed the Newcastle findings. Columns
A and C are from suspensions without EF and
therefore, as expected, show no difference
betwTeen "' normal " and " malignant "
samples. The fall in the numbers in A, B
and C reflects increasing experience with the
technique and wAith the Cytopherometer.
The larger numbers in B compared with A
and C suggest that a small proportion of
macrophages fail to react with the MSF and
therefore give " fast " pairs which fall into
the "wrong " category for column B. The
suspension in column D should show no
reaction, and therefore numbers in D should
run parallel to numbers in A and C. The
large and rather erratic number ofslowed cells
in column D, not present in A or C and not
improving with operator experience, suggests
a noh-specific EF-stimulated guinea-pig lym-
phocyte reaction varying from pig to pig (or
batch to batch). Since entries in column D
TABLE II. Percentage Rate of Pairs of
Wrong" Timings from Groups of 10
"Malignant " or 5 "Normal " Samples
" Malignants" "Normals "
A B C D
No EF With EF No EF With EF
13
10
12
0
0
33
35
23
15
7
22
6
12
4
2
16
2
18
28
14
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represent" slowr " timings which are therefore
wrong " from a " normal " subject, they
wNould be right " timings if recorded from a
a malignant" sample containing EF, and
therefore a non-specific reaction of the type
postulated would not show up in column B,
but would just add to the much more numer-
ous cancer-stimulated slowed cells.
The percentage change in mobility induced
by the antigen is 100 (T C)/C where T is the
average migration time for macrophages in
the test suspension containing lymphocytes,
macrophages and antigen, and C isthe average
time from the control suspension without
antigen. There is no advantage in converting
timings into absolute mobilities for this test,
so long as measurements are done in one type
of apparatus only, with factors such as
temperature, voltage or current, pH etc. held
constant. All the timings reported here were
made over a distance of 16 um in medium 199
at pH 7-2 and 23 0+0Q05°C, using a stabilized
current of 9-5 mA which in our Cytophero-
meter required a voltage of 200-190 V
depending on electrode polarization.
RESULTS
This investigation was carried out
between May 1971 and August 1972.
Blood samples from 333 sources were
examined with the MEM test. At first it
proved extremely difficult to obtain the
consistent results claimed by Field and
Caspary. We now know that for the first
230 samples a number of adverse factors
were operating, often together, making
the development of a satisfactory tech-
nique both difficult and time-consuming.
These problems are outlined briefly in the
following points: (a) prior to November
1971 all electrophoretic measurements
were made in an apparatus built in this
hospital. Although our apparatus was
quite capable of accurate and consistent
performance in straight electrophoresis,
we now know that in its original form it
could not give correct results in the MEM
test due to the use of platinized platinum
electrodes. Subsequent experiments
showed that macrophage slowing is lost
in the presence of platinized platinum
electrodes, although clean unplatinized
platinum shows no such effect. This
unexpected " poisoning " awaits further
investigation. In November 1971 the test
was transferred to the Zeiss Cytophero-
meter in which most ofthe results reported
here were obtained. Since it is not
possible to determine retrospectively the
extent to which the " poisoning " was
operating from day to day, it is difficult
to correlate the poor results from the first
230 samples with the " adverse factors "
listed here. A detailed account of the
early results is therefore oflittle value and
is omitted. (b) In many early blood
samples the lymphocyte yields were low
(less than 105/ml); improvements in the
preparation techniques as the work pro-
gressed resulted in substantially increased
yields, an important factor for the success
ofthe test, as shown in Table III. (c) The
TABLE III. Dependence of Macrophage
PercentageSlowingon number ofLympho-
cytes/ml in Test Suspension
Lymphs/ml
Without EF
lO-x 105
1 25x 106
With
100 ug EF
0
10/X 105
2 5x 105
5.0 x 105
1 25x 106
2 5x 106
MIean time
(sec)
3 04
,3 03
3 04
3-39
:3-43
3-48
3-63
3.75
0 Slowing
0
0 3
11*8
13-3
14-8
19-8
23-8
facilities originally available to us pre-
vented effective isolation of the guinea-
pigs used in the test. Guinea-pigs are
prone to infections from other laboratory
animals and from humans, and this
sensitizes the animals, which renders the
macrophages less effective in the MEM
test (Diengdoh and Turk, 1968). Hartley
albino pure bred guinea-pigs free from
infection were not always available in the
early stages of the work, and other
unspecified strains were sometimes used
until the importance of this factor was
realized. The later samples on which this
report is based were examined againstTHE MEM TEST FOR MALIGNANT DISEASE
infection-free Hartley albino pigs from a
closed breeding colony or obtained from a
single reliable source. (d) Macrophages
are easily identified in the Zeiss Cyto-
pherometer because they contain liquid
paraffin droplets. However, experience
and a period of training seem to be
necessary before reproducible results can
be obtained. As soon as one operator
becomes " familiar " with the somewhat
temperamental Cytopherometer there is a
tendency to depend on that person for
measurements. The urgency of accumu-
lating reliable data precludes the time-
consuming investigation that would be
needed to assess the real significance of
operator-dependent factors. For this
reason our electrophoretic measurements
were made by one operator (JAVP).
This paper is based on the last 103
consecutive samples measured, starting
from May 1972 when the adverse factors
outlined above had been effectively elimi-
a
6
4
2
14
12
10
8
6
4
2
nated. The first 79 of these samples
provided independent confirmation of the
MEM test as described by Field and
Caspary. These results have been
described in detail elsewhere (Pritchard et
al., 1972) and in this paper they are
condensed (along with the later results)
into the histogram of Fig. ]. This shows
the clear separation into a "normal"
group with percentage slowing not greater
than 300 and a " malignant " group with
percentage slowing not less than 1300.
The absence of overlap is fully confirmed
by our results. One sample, thought at
the time to be " normal ", gave a percen-
tage slowing of 1900 (later repeated as
210%) in the middle of the " malignant "
range. On further investigation, the
subject was found to have a history of
sarcoidosis, one of the few non-malignant
conditions reported by Field and Caspary
as giving a positive result in the MEM
test. Two further sarcoidosis subjects
'NORMAL'
ISARCOID'
*l.
-2 0 2 4 6 8 10 12 14
% SLOWING
16 18 20 22 24 26 28
14 16 18 20 22 24 26 28
I.-Histogram showing macrophage percentage slowing in the MEM test on 100 blood
samples from healthy controls and patients with malignant disease.
F I.]
56 J. A. V. PRITCHARD, J. L. MOORE, W. H. SUTHERLAND AND C. A. F. JOSLIN
% SLOWING
A
DOSE (RAD)
500 1000 1500 2000 2500
FIG. 2. Dependence of percentage slow-ing in the AMEMI test on ra(liation (lose to the guiinea-pig
macrophage suspension for 4 " malignant " (solid lines) and 1 " normal " (broken line) samples.
were added later, with similar results, to
give the small group of 4 positives in the
upper section of Fig. 1. Otherwise, all
our " normal " subjects were healthy
hospital staff. The rest of this paper
presents a preliminary account of our
early attempts to improve the test towards
future clinical use.
With better understanding of the test
improvement should be possible under 3
headings: (1) simplification of the electro-
phoresis apparatus and technique; (2)
simplification of the sample handling and
preparative procedures; (3) greater separa-
tion of the " malignant " and "normal
results. It is to be expected that these 3
aspects are considerably interdependent;
for example, an improvement in (3) could
be expected to relax the requirements for
(2) and (1). Some progress has already
been made under (1) but a discussion of
apparatus considerations will be presented
separately. Under heading (2) the Ficol-
Triosil technique oflymphocyte separation
already represents a considerable simpli-
fication. This technique always produced
very good yields of lymphocytes with
minimal contamination by polymorphs
and red cells, and requires only 60 mim of
sample preparation time in contrast to the
130 min required by the methylcellulose
technique specified by Field and Caspary.
Wte have also found that storage of the
separated lymphocytes for 24 hours at
4°C produces no significant change in
macrophage percentage slowing, and that
storage for 72 hours at 4°C is possible with
some reduction in slowing.
Several improvements have been in-
troduced under (3). Percentage slowing
can be increased by using a larger con-
centration of lymphocytes/ml in the
reaction mixture, as shown for one
typical " malignant " sample in Table III.
No corresponding effect was fotind with
" normal " samples. The macrophages
used in the first part of this investigation,
leading to Fig. 1, were irradiated to a dose
of 150-200 rad, as used by Field and
Caspary. This dose was sufficient to
eliminate most of the mixed lymphocyte
interaction, but was not sufficient to
achieve maximum slowing, as shown in
Fig. 2, in which percentage slowing is
mr. ITHE MEM TEST FOR MALIGNANT DISEASE
TABLE IV.-Effectof Radiation Dose and Incubation Regimen on MacrophagePercentage
Slowing in the MEM Test
Split incubation:
Single stage incubation at: Lymphocytes + EF at 23°C:
Supernatant + macrophages at:
230C 230C 370C 230C 370C 370C 370C
0 rad 200 rad 200 rad 200 rad 0 rad 200 rad 2500 rad
A B C D E F G
" Malignants "
21 0
16-8
18-4
18-3
17-3
16-6
17-2
16-6
15-6
0.1 -0.1
1-8 2-0
plotted against radiation dose for 4
" malignant " and 1 " normal " samples.
The use of high radiation doses could
hardly be described as a simplification of
the test, and therefore alternative methods
were sought foreliminatingthe mixed lym-
phocyte interaction completely. Incuba-
tion was split into two stages: first, the
patient's lymphocytes were mixed with
EF and incubated for 90 min at either
23°C or 37TC to stimulate the release of
MSF; lymphocytes were then removed
from this suspension by centrifugation and
the cell-free supernatant was added to the
macrophage suspension for a second 90
min incubation at 23TC or 37TC. In this
way, human lymphocytes did not come
into contact with the guinea-pig lympho-
cytes present in the macrophage suspen-
sion, and therefore a mixed lymphocyte
interaction should not occur, thus remov-
ing the need for prior irradiation. Table
IV presents the combined results of a
number of experiments of this type, from
which the following conclusions emerge,
some of which require further investi-
gation: (1) column B represents the result
of the test as developed by Field and
Caspary, and is now confirmed by our
results. (2) There is no benefit in raising
the temperature of the complete mixture
from 230C to 370C during single stage
- 24-0 -
15-0 17-0 -
17-0 17-9
18-9 18-2 -
- - 21 4
- 18-2
18-6
" Normals "
-1*0
40*0
27-0
30 5
32-3
25-8
25 1
29-0
22-6
30 0
-0 7
0-2 1*3
25-8
28-6
22-8
1. 8
incubation (columns C/B). (3) Results are
unaffected when incubation at 23TC is
split into two stages, showing that MSF
is a soluble factor released by the inter-
action of sensitized lymphocytes with EF
(columns D/B). (4) When human and
guinea-pig lymphocytes are kept apart by
split incubation, mixed lymphocyte in-
teraction is no longer a problem, and
irradiation of the macrophage suspension
can be omitted without loss of result
(columns E/B). (5) A large improvement
in the MEM test is obtained when
macrophages which were previously irra-
diated to at least 200 rad are incubated
for 90 min at 37TC with cell-free supernat-
ant containing MSF (columns F/B). (6)
Usingtheincubationregimenjustdescribed,
no further improvement is seen with doses
larger than 200 rad (columns G/F). (7)
The results from " normal " subjects are
unaffected by these changes in irradiation
and incubation.
DISCUSSION
This investigation has confirmed the
results of Field and Caspary (1970) and
Caspary and Field (1971) and verifies the
MEM test as an in vitro laboratory tech-
nique for the detection of malignant
disease. All patients with malignant
Sample
number
322
323
326
327
329
328
330
331
333
325
332
1 8
0-5
1.0
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disease in our series gave macrophage
percentage slowing between 13%0 and
29%, while all healthy controls (with the
exception of 3 sarcoidosis subjects) were
below 3.4%0 (Fig. 1), thus emphasizing
again the absence of overlap between
" malignant " and ' normal " subjects.
The absence of overlap to date suggests
that it may prove difficult to investigate
the rise in sensitization during early
neoplastic involvement, since subjects may
pass quickly through this stage to a full
positive MEM response. Wre have not
found the sensitization of laboratory staff
to EF reported from Newcastle, but this
may come in the future with increased
exposure to the antigen.
Table III shows the importance of
maintaining a high concentration of
lymphocytes/ml. Fig. 1 and Table IV
were obtained with numbers in the range
1 x 106/ml-5 x 1061ml, at which percen-
tage slowing is approaching a maximum.
In addition to maintaining the necessary
high lymphocyte yield and requiring a
shorter preparation time, the Ficol-Triosil
method adopted by us as standard, gave
minimal contamination by polymorphs
and red cells, an important factor when
training an inexperienced operator. W7e
have found that "wrong" pairs of
timings were more numerous on days when
the macrophage suspension was contami-
nated with red cells, although the reason
for this is not clear.
The split incubation technique
described above increases percentage slow-
ing from " malignant " samples into the
range 220o-4000 without any apparent
change in the result from "normal"
subjects, as shown in Table IV. Table IV'
provides a direct comparison between the
test as described by Field and Caspary
(column B) and the Cardiff-modified
MEM test of column F, which has now
been adopted as our standard procedure
and as a basis for further simplification
and development. This change in sample
handling has greatly increased the already
wide gap between " malignant " and
" normal " subjects, which is an important
step towards possible clinical use of the
MEM test. This larger difference reduces
the possibility of false results, is more
easily seen by an inexperienced operator,
and may lead to simpler techniques for
greater convenience in putting the test
into practical use. For example, using the
incubation regimen of column E in Table
IV it is possible to dispense with irradia-
tion while still retaining a percentage
slowing slightly higher than that provided
by the original Newcastle methods. It is
not yet clear why irradiation of the
macrophage suspension to 200 rad should
increase the percentage slowing to the
values in column F of Table IV, since
mixed lymphocyte interaction should be
absent, and this requires further investi-
gation.
Results are not yet available in our
series from a population of " normals "
with a wide variety of non-malignant
illnesses, and much laboratory work
remains to be done before the MEM test
can be used as a routine clinical procedure.
Even with simplification ofthe techniques,
the test will have limited value as a
screening procedure unless the patient has
specific localizing signs or symptoms,
since there is at present no simple way to
locate early malignant disease, except for
a few sites such as cancer ofthe cervix. In
view of this we are now applying the
MEM test to situations where it can be
used in conjunction with existing clinical
and ancillary investigations; this includes
an evaluation of its usefulness for diag-
nosing malignancy in female breast swell-
ings, the results of which we hope to
publish in the near future.
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